(redirected from Cervical dysplasia)
Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.


Abnormal development or growth of tissues, organs, or cells.

dys·plas′tic (-plăs′tĭk) adj.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.


(Anatomy) abnormal development of an organ or part of the body, including congenital absence
[C20: New Latin, from dys- + -plasia, from Greek plasis a moulding]
dysplastic adj
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014


(dɪsˈpleɪ ʒə, -ʒi ə, -zi ə)

abnormal growth or development of cells, tissue, bone, or an organ.
[1930–35; dys- + -plasia]
dys•plas′tic (-ˈplæs tɪk) adj.
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.


Abnormal development or growth of tissues, organs, or cells.

dysplastic adjective
The American Heritage® Student Science Dictionary, Second Edition. Copyright © 2014 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.dysplasia - abnormal development (of organs or cells) or an abnormal structure resulting from such growth
aplasia - failure of some tissue or organ to develop
fibrous dysplasia of bone - a disturbance in which bone that is undergoing lysis is replaced by an abnormal proliferation of fibrous tissue resulting in bone lesions or skin lesions
hypertrophy - abnormal enlargement of a body part or organ
hyperplasia - abnormal increase in number of cells
hypoplasia - underdevelopment of an organ because of a decrease in the number of cells
anaplasia - loss of structural differentiation within a cell or group of cells often with increased capacity for multiplication, as in a malignant tumor
abnormalcy, abnormality - an abnormal physical condition resulting from defective genes or developmental deficiencies
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.


n. displasia, cambio o desarrollo anormal de los tejidos.
English-Spanish Medical Dictionary © Farlex 2012


n displasia, desorden f de crecimiento en un tejido
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
* Coverage of the Cervical Dysplasia pipeline on the basis of route of administration and molecule type.
The data highlighted in this article come from an excellent study that has shed more light on the long-held misconception that HIV-infected women have a higher risk of cervical dysplasia and, perhaps, cervical cancer.
The International Journal of Gynecologic Cancer reports the finding of Korean researchers of a lower risk of cervical intraepithelial neoplasia (also known as cervical dysplasia) among human papilloma virus-positive women who consumed vitamin supplements.
Some conditions, such as cervical dysplasia, erythroplasia or xeroderma pigmentosum are believed to serve as biomarkers for carginogenesis.
Palefsky said he examines for anal dysplasia the same way one does for cervical dysplasia. He inserts a water-moistened Dacron swab into the anus and rubs the swab around the wall of the canal.
However, 43% of the obstetrician-gynaecologists said they had performed a hysterectomy in the previous year to treat mild or moderate cervical dysplasia, which is not recommended practice.
They used a Markov model of cervical dysplasia progression to predict the risk of invasive cancer in the next 3 years, assuming yearly follow-up screening or screening 3 years after the last normal result.
Pre-clinical studies have shown that Matritech's NMP179 can identify both low- and high-grade cervical dysplasia, by detecting the nuclear matrix protein that is produced by cervical carcinomas.
ZYCOS' drug is currently in a multinational Phase II clinical trial in patients diagnosed with high-grade cervical dysplasia.
Noncompliance in screening follow-up among family planning clinic patients with cervical dysplasia. Prev Med 1985;14:248-58.
Prior study results utilizing Inovio's VGX-3100 immunotherapy, which is also in a Phase 3 trial evaluating treatment for cervical dysplasia, supported expanding treatment indications for patients associated with HPV-16 and/or HPV-18.